PolitiKit

Advancing a National Children's Strategy to advance child and youth health and well-being outcomes.

Advancing federal and provincial health alignment around child and youth healthcare policies.

Advocate for the implementation of a federal diabetes and obesity strategy.

Monitor all developments regarding Health Canada regulation of vaping products.

ADMINISTRATIVE BURDEN: Advocate for measures to alleviate the administrative burden on physicians and support their professional wellbeing, including investment to facilitate the development of EHRs and EMRs in Canada, improved remuneration for the completion of federal health forms, the development of a Federal Disability Benefit, ensuring that physicians are not captured in the definition of "promoters" in the Disability Tax Credit Promoters Restrictions Regulations, providing clarity and guidance on federal forms, and advocacy on discontinuing the requirement that employees present sick notes to their employers.

PAN CANADIAN LICENSURE: Advocate for the ability for physicians with full licences to practise independently without restrictions or for medical resident trainees registered in any Canadian jurisdiction to practise or train in any other Canadian jurisdiction without having to acquire more than one licence or pay additional licensing fees. This includes exploring enabling legislation in the provinces and territories.

Create a national licensure framework for nurses

Harmonize nursing regulatory practices to support a responsive and sustainable nursing workforce

Allow nurses to certify the Disability Tax Credit form

Create a pan-Canadian health human resources strategy

Amendments to the Food and Drugs Act – Ensure sensible rules for natural health products. Address prohibition on sampling of natural health products directly to the consumer. Implication of Health Canada’s proposed Consumer Health Products Framework. Consideration of the 53 recommendations made in 1998 by the Standing Committee on Health.

Government of Canada program and policy support for the natural health product, food, health product and overall commodity manufacturing sector's.

Scientific and analytical integrity in Health Canada's regulatory proposal Canada Gazette I & II, Volume 155, Number 26 and all other recent labeling laws including but not limited to Canada Gazette, Part II, Volume 156, Number 15.

Matters related to trade with USA as they related to trade policies, tariffs, trade agreements, regulatory reform, retaliatory measures, tariff policy, remissions/relief policies considered by the federal government, provincial impact of implementing tariffs, etc.

Amendments to the Food and Drugs Act – Ensure sensible rules for natural health products. Address prohibition on sampling of natural health products directly to the consumer. Implication of Health Canada’s proposed Consumer Health Products Framework. Consideration of the 53 recommendations made in 1998 by the Standing Committee on Health.

Interactions with Government officials regarding in-service support for Halifax Class Frigates.

Trade-related matters, including policies and tariffs impacting medicines and vaccines.

Access to medicines - government policies, processes, legislation, and/or regulation with potential impact on access to medicines in Canada.

Patented Medicines Review Board (PMPRB), certified under the Patent Act and whose guidelines seek to ensure a balance between the prices set by manufacturers for patented medicines sold in Canada and the maintenance of an attractive environment for pharmaceutical research and development. Specifically with regard to ensuring that any actions and proposed changes by the PMPRB are consistent with the mandate assigned by Parliament.

HEALTH RESEARCH: Focus on increasing public investments across the research spectrum of operating grants, people and infrastructure and encourages investments from private and private-not-for-profit sectors.

INDUSTRY: Advocate for policies that enhance the health and biosciences sector’s capacity to do business in Canada and to invest in Canadian health research and commercialization.

DIGITAL HEALTH: Increased investment in providing digital, virtual and telehealth services.

ADMINISTRATIVE BURDEN: Advocate for measures to alleviate the administrative burden on physicians and support their professional wellbeing, including investment to facilitate the development of EHRs and EMRs in Canada, improved remuneration for the completion of federal health forms, the development of a Federal Disability Benefit, ensuring that physicians are not captured in the definition of "promoters" in the Disability Tax Credit Promoters Restrictions Regulations, providing clarity and guidance on federal forms, and advocacy on discontinuing the requirement that employees present sick notes to their employers.

TECHNOLOGY AND ARTIFICIAL INTELLIGENCE: provide CMA’s perspective on the impact of technology and artificial intelligence on the health care sector including input on Bill C-27, and the means through which advancements can be foreseen and managed.

TECHNOLOGY AND ARTIFICIAL INTELLIGENCE: provide CMA’s perspective on the impact of technology and artificial intelligence on the health care sector including input on Bill C-27, and the means through which advancements can be foreseen and managed.

DIGITAL HEALTH: Increased investment in providing digital, virtual and telehealth services.

ADMINISTRATIVE BURDEN: Advocate for measures to alleviate the administrative burden on physicians and support their professional wellbeing, including investment to facilitate the development of EHRs and EMRs in Canada, improved remuneration for the completion of federal health forms, ensuring that physicians are not captured in the definition of "promoters" in the Disability Tax Credit Promoters Restrictions Regulations, and advocacy on discontinuing the requirement that employees present sick notes to their employers.